Static Chart Immix Biopharma, Inc.

Equities

Delayed Nasdaq Other stock markets 15:40:23 05/06/2024 BST			5-day change	1st Jan Change
1.983 ^USD	+9.54%		-9.06%	-71.35%

05-10	Immix Biopharma, Inc. Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Latebreaking Oral Presentation	CI
05-09	Immix Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Duration

Period